Progesterone Market Size (By Type, By Mode Of Delivery, By Application, By Distribution Channel, and By Geography) - Global Industry, Share, Analysis, Trends and Forecast 2024 – 2032

Progesterone Market Highlights

• Global progesterone market revenue is poised to garner USD 3.38 billion by 2032 with a CAGR of 13.2% from 2024 to 2032
• North America progesterone market value occupied around USD 436.9 million in 2023
• Asia-Pacific progesterone market growth will record a CAGR of more than 14% from 2024 to 2032
• Among type, the natural progesterone sub-segment generated 59% of the market share in 2023 due to natural hormone therapies
• Based on mode of delivery, the injectable sub-segment generated around 37% market share in 2023 due to accurate dosing and rapid absorption
• Growing need for women’s healthcare is a progesterone market trend that fuels the industry demand

Progesterone is a naturally occurring hormone primarily produced in the ovaries in females, and in smaller amounts in the adrenal glands in both genders. It plays a crucial role in the menstrual cycle, pregnancy, and embryogenesis. Progesterone is often referred to as the "pregnancy hormone" because of its essential role in maintaining the uterine lining for successful implantation of the fertilized egg and supporting early pregnancy. In addition to its reproductive functions, progesterone also has various other roles in the body, including regulating metabolism, promoting bone health, and supporting the immune system. Additionally, progesterone is commonly used in hormone replacement therapy for menopausal women to improve symptoms such as hot flashes and vaginal dryness. It is also used in assisted reproductive technology (ART) to support embryo implantation and in the treatment of certain menstrual disorders.

Global Progesterone Market Dynamics

Market Drivers

• Increasing cases of amenorrhea, breast and uterine cancer and AIDS
• The growing infertility rates across developed and developing countries
• Increasing prevalence of hormonal disorder

Market Restraints

• Side effects associated with progesterone treatment
• Lack of awareness of progesterone therapy’s availability in underdeveloped countries

Market Opportunities

• Growing research & development activities
• Favorable government initiatives and healthcare policies

Progesterone Market Report Coverage

Progesterone Market Insights

The increasing cases of amenorrhea, breast and uterine cancer and AIDS drive the demand for progesterone market. For instance, each year, 30% of breast cancer cases are registered in the U.S., creating approximately 287,000 cases annually. Progesterone is a hormone important for regulating menstrual cycles and supporting pregnancy. This is utilized in various treatments regarding women’s health issues. In cases of amenorrhea, progesterone therapy can help to restore menstruation cycles. Additionally, progesterone plays vital role in hormone replacement therapy for breast and uterine cancer patients. Furthermore, in AIDS management, progesterone has benefits in immune system modulation. As a result, the increasing prevalence of these conditions, is driving demand for progesterone industry. Moreover, growing infertility rates across developed and developing countries and increasing prevalence of hormonal disorder further boosts the demand of market. For instance, according to World Health Organization (WHO), 48 million couples and 186 Million individuals have infertility. These factors further contribute to the market growth.

Lack of awareness of progesterone therapy’s availability in underdeveloped countries hinders the growth of the progesterone market. This lack of awareness comes from various factors including insufficient healthcare infrastructure, limited access to information, and economic challenges. As a result, many individuals in these regions may not have access to or be aware of the benefits of progesterone therapy for various medical conditions. Due to these issue requires efforts to improve healthcare infrastructure, raise awareness about progesterone therapy for the growth of the progesterone market in underdeveloped countries.

Growing research & development activities creates a significant opportunity for the progesterone market. For instance, in February 2020, Besins Healthcare initiated the manufacturing of Utrozhestan (progesterone) medication in Russia, utilizing the resources of its domestic facility located in the Yaroslavl region. These R&D efforts drive innovation, leading to the development of more effective and diverse products for the medical improvement. For instance, in December 2019, Mankind Pharma launched Dydrogesterone tablets in India to treat infertility problems and also for the complications during pregnancy. Moreover, investment in research and development activities and government initiatives further boosts the market growth. Thus, the progesterone market significantly increases, by the ongoing advancements and growing research and developments.

Progesterone Market Segmentation

The worldwide market for progesterone is split based on type, mode of delivery, application, distribution channel, and geography.

Progesterone Types

• Natural Progesterone
• Synthetic Progesterone

According to the progesterone industry analysis, natural progesterone dominates the market. There is a surge in demand for bioidentical and natural hormone therapies which leads to preferred choice for organic and plant-derived products and rising the advantages of natural progesterone. Additionally, natural progesterone plays a vital role in balancing the hormones and drives the growth of this segment. Furthermore, it is crucial in manopause management, reproductive health, and therapies of hormonal replacement with few side effects further contributing to the segment dominance in the progesterone market.

Progesterone Mode of Deliveries

• Injectable
• Suspended Form
• Oral

By mode of delivery, the injectable segment registered the maximum share in 2023 and is projected to maintain its dominance over the forecast period 2024-2032 due to their efficacy and convenience in administration. For instance, in May 2022, Xiromed LLC introduced the Progesterone Injection USP in a 500 mg/10 ml multiple-dose vial, offering a generic alternative to the existing progesterone injection USP at 50 mg/ml. Injectable forms offer accurate dosing and rapid absorption into the bloodstream. Additionally, they are preferred in clinical settings for their ease of administration by healthcare professionals. This highlights the importance of injectable progesterone formulations in a wide range of therapeutic requirements for patients, including hormone replacement therapy and reproductive health management.

Progesterone Applications

• Regulation of the Menstrual Cycle
• Dysfunctional Uterine Bleeding
• Endometrial Cancer
• Contraception
• Hyperplastic Precursor Lesions

According to the progesterone market forecast, the regulation of the menstrual cycle segment is expected to dominate the progesterone market due to its crucial role in women's reproductive health. Progesterone, a hormone produced primarily by the ovaries, plays a vital part in preparing the uterus for pregnancy and regulating menstruation. Factors such as hormonal imbalances, irregular periods, and fertility issues drive the demand for progesterone-based medications in this segment. Moreover, rising awareness about reproductive health, advancements in healthcare technologies, further boost the market growth.

Progesterone Distribution Channels

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

According to the progesterone industry analysis, hospital pharmacy as a distribution channel dominates the progesterone market due to their pivotal role in efficiently distributing medications to patients. Hospital pharmacies are essential parts of healthcare facilities. Their direct link to healthcare providers and patients allows for coordination of prescriptions ensuring smooth access to necessary medications. Additionally, hospital pharmacies often have robust infrastructure and expertise to handle dosage requirements, with the need of patients. Overall, this direct access makes hospital pharmacies the primary distribution channel for progesterone medications.

Progesterone Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of LATAM

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Progesterone Market Regional Analysis

In terms of progesterone market analysis, North America dominates the regional market. Firstly, the region’s advanced healthcare infrastructure and widespread access to pharmaceutical products, facilitating robust demand for hormone therapies like progesterone. For instance, according to Healthcare Infrastructure and Management System Society, to modernize Territorial, state, and Local and Tribal (STLT) public health infrastructure HIMSS recommends total investment of about $36.7 billion over 10 years across the U.S. Additionally, the presence of leading pharmaceutical companies and research institutions creates innovation and development in hormone-related treatments, further maintaining North America's position as a key market player. Moreover, favorable government regulations and policies contribute to the market's growth by encouraging investment and product availability. Overall, these factors maintain North America’s dominance in the progesterone market.

Asia-Pacific is the fastest growing region in the progesterone market. Firstly, increasing awareness and acceptance of hormonal therapies, including progesterone, for various medical conditions such as infertility, menopause, and hormonal imbalances, are driving demand. For instance, FDA approved Veozah in May 2023, to reduce symptoms such as flushing and sweating in womens. Additionally, the rising prevalence of gynecological disorders contributes to the growing need for progesterone-based treatments. Furthermore, government initiatives at improving women's health and access to reproductive healthcare services and developments by key players play a pivotal role in increase market growth. For instance, in Japan, Fuji Pharma Co., Ltd launched the natural progesterone drug i.e. F-meno capsule 100 mg in November 2021. As a result, these factors make Asia Pacific as a fastest-growing region in this sector.

Progesterone Market Players

Some of the top progesterone companies offered in our report includes Aquatic Remedies Pvt. Ltd., Bionpharma Inc., Teva Pharmaceuticals Industries Ltd, Sofgen Pharmaceuticals, Wuhan Honor Bio-Pharm Co., Ltd, Estrellas Life Sciences Private Limited, Intas Pharmaceuticals Ltd., Shanghai Yijing Industrial Co., Ltd., Virtus Pharmaceuticals Llc, and Blubell Pharma Group Company.